Home Cart Sign in  
Chemical Structure| 205923-56-4 Chemical Structure| 205923-56-4

Structure of Cetuximab
CAS No.: 205923-56-4

Chemical Structure| 205923-56-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cetuximab is a chimeric IgG1 monoclonal antibody that prevents the binding of ligands to the EGFR extracellular domain by binding to it. Cetuximab has potential for research in squamous cell carcinoma of the head and neck and colorectal cancer.

Synonyms: C225

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cetuximab

CAS No. :205923-56-4
M.W : 145.56 kDa
SMILES Code : NONE
Synonyms :
C225
MDL No. :MFCD06407972

Safety of Cetuximab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Cetuximab

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

    EGFR, Kd:0.39 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
NK cells 10 μg/mL 24 hours To evaluate the killing effect of NK cells on HNSCC cells in the presence of Lirilumab, results showed that Lirilumab significantly enhanced NK cell-mediated killing of tumor cells. Head Neck. 2019 Aug;41(8):2591-2601
IL-1R1 stable knockdown SQ20B cells 1, 10, and 100 μg/mL 48 h IL-1R1 knockdown significantly suppressed cetuximab-induced cytokine secretion. J Immunother Cancer. 2019 Mar 19;7(1):79
MyD88 stable knockdown SQ20B cells 1, 10, and 100 μg/mL 48 h MyD88 knockdown significantly suppressed cetuximab-induced cytokine secretion. J Immunother Cancer. 2019 Mar 19;7(1):79
SQ20B cells 1, 10, and 100 μg/mL 48 h Cetuximab at a dose of 100 μg/mL significantly increased IL-1α and IL-8 secretion, and increased IL-6 secretion at all tested concentrations. J Immunother Cancer. 2019 Mar 19;7(1):79
Cal-27 cells 1, 10, and 100 μg/mL 48 h Cetuximab at a dose of 100 μg/mL significantly increased IL-1α, IL-6, and IL-8 secretion. J Immunother Cancer. 2019 Mar 19;7(1):79
DLD-1 100 μg/ml 24 h To evaluate the cytotoxic and antiproliferative effects of Cetuximab combined with RSL3 on KRAS mutant CRC cells. Results showed that the combination treatment significantly inhibited cell viability and proliferation. Cell Death Dis. 2021 Nov 13;12(11):1079
HCT116 100 μg/ml 24 h To evaluate the cytotoxic and antiproliferative effects of Cetuximab combined with RSL3 on KRAS mutant CRC cells. Results showed that the combination treatment significantly inhibited cell viability and proliferation. Cell Death Dis. 2021 Nov 13;12(11):1079
C10 1 ng/µL 72 h To assess the efficacy of targeting the AURKA/YAP1 axis to overcome cetuximab resistance Br J Cancer. 2024 May;130(8):1402-1413
SW48 10 ng/µL 72 h To assess the efficacy of targeting the AURKA/YAP1 axis to overcome cetuximab resistance Br J Cancer. 2024 May;130(8):1402-1413
HCT116 cells 0.1 μM or 1 μM 24 h To evaluate the effect of Cetuximab on EGFR protein expression. Results showed that Cetuximab only marginally affected EGFR levels in HCT116 cells. J Nucl Med. 2018 Oct;59(10):1558-1565
H1975 cells 0.1 μM or 1 μM 24 h To evaluate the effect of Cetuximab on EGFR protein expression. Results showed that 0.1 μM Cetuximab reduced EGFR protein expression by 3-fold in H1975 cells, while the effect was slightly attenuated at the higher dose (1 μM). J Nucl Med. 2018 Oct;59(10):1558-1565
UMSCC 103 20 μM 48 h Test the cytotoxic effect of Cetuximab on UMSCC 103, finding significant cell death when combined with ICI Cell Death Dis. 2023 Sep 19;14(9):613
Patient-derived colorectal cancer organoids (PDXO) 20 μg/mL 72 h To evaluate the effect of cetuximab on BIM protein expression, results showed that cetuximab upregulated BIM protein levels. Clin Cancer Res. 2023 Mar 14;29(6):1102-1113
Patient-derived colorectal cancer organoids (PDXO) 20 μg/mL 1 week To evaluate the effect of cetuximab on PDXO cell viability, results showed that cetuximab inhibited cell growth. Clin Cancer Res. 2023 Mar 14;29(6):1102-1113

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Athymic nu/nu mice Cal-27 and SQ20B xenograft models Intraperitoneal injection 2 mg/kg Twice weekly for 2 weeks IL-1 blockade (using anakinra) did not affect the anti-tumor efficacy of cetuximab. J Immunother Cancer. 2019 Mar 19;7(1):79
BALB/c nude mice DLD-1 xenograft model Intraperitoneal injection 13 mg/kg Once daily for 17 days To evaluate the antitumor effects of Cetuximab combined with RSL3 on KRAS mutant CRC xenograft models. Results showed that the combination treatment significantly reduced tumor volume and increased MDA levels. Cell Death Dis. 2021 Nov 13;12(11):1079
Mice Patient-derived xenograft (PDX) models of KRAS-mutated colorectal cancer Intraperitoneal injection 25 mg/kg Twice weekly, for 28 days or longer To evaluate the efficacy of combined Cetuximab and Trametinib therapy in KRAS-mutated CRC PDX models. The combination therapy induced disease control (partial response or stable disease) in 74% of the models analyzed, with 47% achieving partial response. Mol Oncol. 2023 Nov;17(11):2396-2414
Nude mice Orthotopic HNSCC mouse model Intraperitoneal injection 40 mg/kg Every 3 days for 4 weeks Evaluate the effect of Cetuximab alone or in combination with ICI on HNSCC tumor growth, finding significant tumor growth delay with combination therapy Cell Death Dis. 2023 Sep 19;14(9):613
BALB/c nude mice H1975 tumor model (non-small cell lung cancer) and HCT116 tumor model (colorectal cancer) Intravenous injection (Cetuximab) or intraperitoneal injection (Gemcitabine) 10 mg/kg Cetuximab was administered on day 1 or days 1 and 2, Gemcitabine on day 2, and imaging was performed on day 3. To evaluate the effect of Cetuximab alone or in combination with Gemcitabine on tumor growth and biological markers. Results showed that repeated doses of Cetuximab significantly increased 18F-ICMT-11 uptake and cleaved caspase-3 staining in H1975 tumors, while a single dose was insufficient to induce apoptosis but affected proliferation. 18F-FLT uptake was significantly reduced, paralleled by a decrease in Ki-67 and marked tumor growth delay. HCT116 tumors were insensitive to Cetuximab treatment. J Nucl Med. 2018 Oct;59(10):1558-1565
NSG mice CDX-humanized mouse model Intravenous injection 0.4 mg/kg/dose Weekly for 5 weeks Evaluate the antitumor effects of cetuximab in combination with NK cells J Immunother Cancer. 2024 Mar 27;12(3):e008585
NOD/SCID mice Patient-derived xenograft models (PDX) Intraperitoneal injection 20 mg/kg Twice weekly for 5 weeks To evaluate the effect of cetuximab on tumor volume in PDX models, results showed that cetuximab significantly reduced tumor volume. Clin Cancer Res. 2023 Mar 14;29(6):1102-1113

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03524820 Cancer of Colon PHASE2 TERMINATED 2021-12-31 Hadassah Ein Kerem, Jerusalem,... More >> 91120, Israel Less <<
NCT00698841 Advanced Cancer PHASE2 COMPLETED 2025-02-10 Northwest Alabama Cancer Cente... More >>r, Muscle Shoals, Alabama, 35661, United States|Donald W. Hill, MD, Casa Grande, Arizona, 85222, United States|Compassionate Cancer Care Medical Group, Inc, Corona, California, 92879, United States|Compassionate Cancer Care Medical Group Inc, Fountain Valley, California, 92708, United States|Pacific Shores Medical Group, Long Beach, California, 90813, United States|Desert Hospital Comprehensive Cancer Center, Palm Springs, California, 92262, United States|Compassionate Cancer Care Medical Group, Inc, Riverside, California, 92501, United States|American Institute Research, Whittier, California, 90603, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Baptist Cancer Institute, Jacksonville, Florida, 32207, United States|Ocala Oncology Center, Ocala, Florida, 34471, United States|Brinz, Burroff, Gurtler, & Russo, Metairie, Louisiana, 70006, United States|Cancer Specialists Of Oklahoma, Oklahoma City, Oklahoma, 73112, United States|Pharma Resource, East Providence, Rhode Island, 02915, United States|Austin Cancer Centers, Austin, Texas, 78759, United States|Local Institution, San Juan, 00910, Puerto Rico Less <<
NCT00251381 Oropharyngeal Neoplasms PHASE2 UNKNOWN 2025-11-09 Hospital Germans Tries i Pujol... More >>, Badalona, Barcelona, 08196, Spain|Institut Catala Oncologia: Hospital Duran y Reynals, Hospitalet de Llobregat, Barcelona, 08097, Spain|Centro Oncológico Regional de Galicia, A Coruna, Coru?a, 15009, Spain|H.U. Virgen de la Arrixaca, El Palmar, Murcia, 30120, Spain|Hospital de Navarra, Pamplona, Navarra, 31008, Spain|H. U. de Canarias, Santa Cruz de Tenerife, Sta Cruz de Tenerife, 38320, Spain|H. del Mar / H. de la Esperanza, Barcelona, 08003, Spain|H. de la Santa Creu I Sant Pau, Barcelona, 08025, Spain|H. Josep Trueta (ICO), Girona, 17007, Spain|H. G. Doctor Negrín, Las Palmas de Gran Canaria, 35020, Spain|Clinica Ruber Internacional, Madrid, 28034, Spain|H. Ramón y Cajal, Madrid, 28034, Spain|Fundación Jiménez Díaz, Madrid, 28040, Spain|H. Gregorio Mara?ón, Madrid, 28040, Spain|Complejo Hospitalario Virgen de la Victoria, Malaga, 29010, Spain|H. Carlos Haya, Malaga, 29010, Spain|H.U. de Santiago, Santiago, 15706, Spain|H. do Meixoeiro, Vigo, 36200, Spain Less <<
NCT01192087 Adenoid Cystic Carcinoma PHASE1|PHASE2 UNKNOWN 2025-07-17 Dept. of Radiation Oncology, H... More >>eidelberg, 69120, Germany Less <<
NCT01382407 Colorectal Cancer Metastatic COMPLETED 2017-04-01 Oncology Institute, Rambam Hea... More >>lth Care Campus, Haifa, 31096, Israel|Rambam Health Care Campus, Haifa, 31096, Israel Less <<
NCT03769311 Head and Neck Cancer|Squamous ... More >>Cell Carcinoma Less << PHASE2 COMPLETED 2022-03-15 University of Wisconsin Carbon... More >>e Cancer Center, Madison, Wisconsin, 53792, United States Less <<
NCT00362102 Colorectal Carcinoma PHASE2 COMPLETED 2025-07-06 -
NCT01051167 Metastatic Colorectal Cancer PHASE2 COMPLETED 2025-09-16 University of Duisburg-Essen M... More >>edical School, Essen, Nordrhein-Westfalen, 45122, Germany|Alfried Krupp von Bohlen und Halbach Krankenhaus gGmbH, Essen, Nordrhein-Westfalen, 45131, Germany|Prosper Hospital Recklinghausen, Recklinghausen, Nordrhein-Westfalen, 45659, Germany Less <<
NCT00791141 Head and Neck Cancer PHASE2 COMPLETED 2025-09-13 Department of Radiotherapy and... More >> Radiological Oncology, University Hospital Munich, Munich, Bavaria, 81377, Germany|Department of Radiotherapeutics of the University Hospital Freiburg, Freiburg, BW, 79106, Germany|Department of Radiological Oncology University Hospital Heidelberg, Heidelberg, BW, 69120, Germany|Department of Radiotherapy and Radiological Oncology University Hospital Tuebingen, Tuebingen, BW, 72076, Germany|Department of Radiotherapy and Radiological Oncology University Hospital Ulm, Ulm, BW, 89091, Germany|Department of Radiotherapy an Radiological Oncology University Hospital Essen, Essen, NW, 45122, Germany|Department of Radiotherapy and Radiological Oncology University Hospital Mainz, Mainz, Rheinland-Pfalz, 55131, Germany|Department of Radiotherapy, University Hospital Schleswig Holstein, Campus Lübeck, Lübeck, Schleswig Hostein, 23538, Germany|Department of Radiotherapy and Radiological Oncology Universit?t Hospital Jena, Jena, Thueringen, 07743, Germany|Charité University Medicine, Department of Radiotherapy and Radiological Oncology, Berlin, 13353, Germany Less <<
NCT00694603 Non-small Cell Lung Cancer PHASE2 TERMINATED 2025-09-09 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT00251498 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2025-10-07 Veeda Oncology, Houston, Texas... More >>, 77042, United States Less <<
NCT00392769 Endometrial Cancer PHASE2 COMPLETED 2025-12-10 New York Presbyterian Hospital... More >>-Cornell Medical Center, New York, New York, 10021, United States|UT MD . Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT05873972 Colorectal Cancer Liver Metast... More >>ases Less << UNKNOWN 2024-12-31 Zhongshan Hospital, Fudan Univ... More >>ersity, Shanghai, Shanghai, 200032, China|Zhongshan hosptial, Fudan University, Shanghai, 200032, China Less <<
NCT00207155 Metastatic Colorectal Cancer PHASE1 COMPLETED 2025-02-06 Local Institution, Duarte, Cal... More >>ifornia, United States|Local Institution, Tampa, Florida, United States|Local Institution, Baltimore, Maryland, United States|Local Institution, St. Louis, Missouri, United States|Local Institution, New Brunswick, New Jersey, United States|Local Institution, Bronx, New York, United States|Local Institution, Cincinnati, Ohio, United States|Local Institution, Cleveland, Ohio, United States|Local Institution, Hershey, Pennsylvania, United States|Local Institution, Philadelphia, Pennsylvania, United States|Local Institution, Nashville, Tennessee, United States|Local Institution, San Antonio, Texas, United States|Local Institution, Montreal, Quebec, Canada|Local Institution, Barcelona, Spain Less <<
NCT01075828 Head and Neck Cancer COMPLETED 2025-07-14 Chungnam National University H... More >>ospital, Jung-gu Daejeon, 301-721, Korea, Republic of Less <<
NCT01142869 Carcinoma, Squamous Cell TERMINATED 2014-08-05 Ambaa Hospitals, Hyderabad, An... More >>dhra Pradesh, 500008, India|Indo- American Cancer Institute & Research Centre, Hyderabad, Andhra Pradesh, 500034, India|NVS Ramakrishna's Clinic, Hyderabad, Andhra Pradesh, 500063, India|Dr. Nikhil's Clinic, Secunderabad, Andhra Pradesh, 500025, India|Swarna Sai Hospital, Secunderabad, Andhra Pradesh, 500059, India|Sparsh Hospital, Orissa, Bhubaneswar, 751007, India|All India Institute of Medical Sciences, New Delhi, Delhi, 110029, India|Wellness Consultants Clinic, Surat, Gujarat, 395002, India|Global Health Pvt Ltd, Gurgaon, Haryana, 122001, India|The Cancer Clinic, Kochin, Kerala, 682304, India|Dr. T. P. Sahoo's Clinic, Bhopal, Madhya Pradesh, 462001, India|BND Onco Centre, Mumbai, Maharashtra, 400014, India|S.L.Raheja Hospital, Mumbai, Maharashtra, 400016, India|S M Karandikar's Clinic, Pune, Maharashtra, 400014, India|Ruby Hall Clinic, Pune, Maharashtra, 411001, India|Galaxy Care Laproscopic Institute, Pune, Maharashtra, 411004, India|Neigrihms, Shillong, Meghalaya, 793005, India|Grace Nursing Home, Aizwal, Mizoram, 796 009, India|Cancer Clinic, Jaipur, Rajasthan, 302004, India|SMS Hospital, Jaipur, Rajasthan, 302004, India|Bhagwan Mahaveer Cancer Hospital, Jaipur, Rajasthan, 302006, India|J.K.Cancer Institute, Kanpur, Uttar Pradesh, 208002, India|Annapurna Medical and Cancer Relief Society, Lucknow, Uttar Pradesh, 226007, India|Dr. Vineet's Clinic, New Delhi, Uttar Pradesh, 110085, India|SMH-Curie Cancer Centre, Shanti Mukand Hospital, New Delhi, Uttar Pradesh, 110092, India|Apollo Gleneagles Cancer Hospital, Kolkata, West Bengal, 700054, India|B.R. Singh Hospital, Kolkatta, West Bengal, 700014, India|Sunil Gupta's Clinic, Delhi, 110092, India Less <<
NCT00492206 Non Small Cell Lung Cancer (NS... More >>CLC) Less << PHASE2 COMPLETED 2025-02-12 Sylvester Comprehensive Cancer... More >> Center, University of Miami, Miami, Florida, 33136, United States|Emory Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, 21231, United States|UPMC Cancer Center -Teramana Cancer Center, Steubenville, Ohio, 43952, United States|UPMC Cancer Center -Beaver, Beaver, Pennsylvania, 15009, United States|UPMC Cancer Center - Clairton, Clairton, Pennsylvania, 15025, United States|UPMC Cancer Center - Oakbrook Commons, Greensburg, Pennsylvania, 15601, United States|UPMC Cancer Center -Arnold Palmer Pavilion, Greensburg, Pennsylvania, 15601, United States|Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|UPMC Cancer Center -Indiana, Indiana, Pennsylvania, 15701, United States|UPMC Cancer Center -John P. Murtha Pavilion, Johnstown, Pennsylvania, 15901, United States|UPMC Cancer Center -McKeesport, McKeesport, Pennsylvania, 15132, United States|UPMC Cancer Center -Haymaker Rd., Monroeville, Pennsylvania, 15146, United States|UPMC Cancer Center -Mosside Blvd., Monroeville, Pennsylvania, 15146, United States|UPMC Cancer Center -Sewickley Medical Center, Moon Township, Pennsylvania, 15108, United States|UPMC Cancer Center -Mt. Pleasant, Mt. Pleasant, Pennsylvania, 15666, United States|UPMC Cancer Center -Jameson, New Castle, Pennsylvania, 16105, United States|UPMC Cancer Center -New Castle, New Castle, Pennsylvania, 16105, United States|UPMC Presbyterian -Radiation Oncology, Pittsburgh, Pennsylvania, 15213, United States|UPMC Cancer Center -Delafield Rd., Pittsburgh, Pennsylvania, 15215, United States|UPMC Cancer Center -St. Margaret, Pittsburgh, Pennsylvania, 15215, United States|Universtity of Pittsburgh Cancer Institute -Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|UPMC Cancer Center -UPMC Shadyside, Pittsburgh, Pennsylvania, 15232, United States|UPMC Cancer Center -Passavant, Pittsburgh, Pennsylvania, 15237, United States|UPMC Cancer Center -Drake, Pittsburgh, Pennsylvania, 15241, United States|UPMC Cancer Center -St. Clair, Pittsburgh, Pennsylvania, 15243, United States|UPMC Cancer Center -UPMC Northwest, Seneca, Pennsylvania, 16346, United States|UPMC Cancer Center -Robert Eberly Pavilion, Uniontown, Pennsylvania, 15401, United States|UPMC Cancer Center -Uniontown, Uniontown, Pennsylvania, 15401, United States|UPMC Cancer Center -Washington, Washington, Pennsylvania, 15301, United States|UPMC Cancer Center -Wexford, Wexford, Pennsylvania, 15090, United States Less <<
NCT01134666 Colorectal Neoplasms TERMINATED 2014-08-05 Indo- American Cancer Institut... More >>e & Research Centre, Hyderabad, Andhra Pradesh, 500034, India|NVS Ramakrishna's Clinic, Hyderabad, Andhra Pradesh, 500063, India|Dr. Nikhil's Clinic, Secunderabad, Andhra Pradesh, 500025, India|Nikhil Gharyalpatil's Clinic, Secunderabad, Andhra Pradesh, 500025, India|Ravi Kumar's Clinic, Hyderabad, Andrapradesh, 500001, India|Ambaa Hospitals, Hyderabad, Andrapradesh, 500008, India|Swarna Sai Hospital, Hyderabad, Andrapradesh, 500059, India|Manipal Centre For Clinical Research, Mangalore, Bangalore, 575 001, India|Medical College Calicut, Kerala, Calicut, 673016, India|Hemato Oncology Clinic, Ahmedabad, Gujarat, 380009, India|Kattimani Oncology Clinic, Hubli, Karnataka, 580020, India|SKIMS, Srinagar, Kashmir, 190001, India|S. K. I. M. S., Srinagar, Kashmir, 190010, India|Dr. T. P. Sahoo's Clinic, Bhopal, Madhya Pradesh, 462001, India|BND Onco Centre, Mumbai, Maharashtra, 400014, India|Joy Hospital, Mumbai, Maharashtra, 400071, India|Ruby Hall Clinic, Pune, Maharashtra, 411001, India|Grace Nursing Home, Aizwal, Mizoram, 796 009, India|Lilavati Hospital, Bandra, Mumbai, 400050, India|S.L.Raheja Hospital, Mahim, Mumbai, 400016, India|Apollo Cancer Institute, Delhi, New Delhi, 110044, India|Rajiv Gandhi Cancer Institute & Research, Delhi, New Delhi, 110085, India|Fortis Escorts Hospital, Amritsar, Punjab, 143004, India|Dr. Rajeev Bedi's Clinic, Chandigarh, Punjab, 160101, India|D.M.C Hospital, Ludhiana, Punjab, 141001, India|IVY Hospital, Mohali, Punjab, 160071, India|Cancer Clinic, Jaipur, Rajasthan, 302004, India|SMS Hospital, Jaipur, Rajasthan, 302004, India|Bhagwan Mahaveer Cancer Hospital, Jaipur, Rajasthan, 302006, India|Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur, Rajasthan, 302030, India|Vyas Cancer Care, Jodhpur, Rajasthan, 3420003, India|TC 14/ 764 Sreemangalam, Trivandrum, Tamilnadu, 695011, India|Shati Gopal Hospital, Ghaziabad, Uttar Pradesh, 201014, India|Annapurna Medical and Cancer Relief Society, Lucknow, Uttar Pradesh, 226007, India|Chittaranjan National Cancer Institute, Kolkata, West Bengal, 700026, India|Apollo Gleneagles Cancer Hospital, Kolkata, West Bengal, 700054, India|Nothern Railway Central Hospital, Delhi, 110055, India|Indraprastha Apollo Hospital, Delhi, 110076, India|Shanti Mukand Hospital, Delhi, 110092, India|Dharamshila Cancer Hospital & Research Centre, Delhi, 110096, India Less <<
NCT02636088 Esophageal Neoplasm PHASE2 UNKNOWN 2025-01-19 -
NCT00207116 Carcinoma, Non-Small-Cell Lung... More >>|Neoplasm Metastasis Less << PHASE1 COMPLETED 2025-03-06 Local Institution, Newark, Del... More >>aware, United States Less <<
NCT01075841 Neoplasms, Squamous Cell WITHDRAWN - -
NCT00315185 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2025-06-08 Consultants in Medical Oncolog... More >>y & Hematology Inc., Drexel Hill, Pennsylvania, 19026, United States Less <<
NCT01326923 Head and Neck Squamous Cell Ca... More >>ncer Less << PHASE2 TERMINATED 2025-02-14 LSU Health Sciences Center, Sh... More >>reveport, Louisiana, 71103, United States Less <<
NCT01074333 Colorectal Neoplasm TERMINATED 2025-01-12 Asan Medical Center, Seoul, Ko... More >>rea, Republic of Less <<
NCT01271439 Nasopharyngeal Carcinoma PHASE2 COMPLETED 2025-12-12 Cancer Center, Sun Yat-sen Uni... More >>versity, Guangzhou, Guangdong, 510060, China Less <<
NCT00865098 Carcinoma of the Head and Neck PHASE2 COMPLETED 2025-06-10 Research Site, Aichi, Japan|Re... More >>search Site, Chiba, Japan|Research Site, Shizuoka, Japan|Research Site, Tokyo, Japan Less <<
NCT00142428 Hepatocellular Carcinoma PHASE2 COMPLETED 2025-10-08 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT01450319 Colorectal Neoplasms PHASE2 COMPLETED 2025-12-14 Research Site, A Coru?a, Spain... More >>|Research Site, Asturias, Spain|Research Site, Barcelona, Spain|Research Site, Cordoba, Spain|Research Site, Madrid, Spain|Research Site, Navarra, Spain|Research Site, Santiago de Compostela, Spain|Research Site, Sevilla, Spain|Research Site, Valencia, Spain Less <<
NCT00422773 Metastatic Colorectal Cancer PHASE1|PHASE2 COMPLETED - Universitaetsklinikum Carl Gus... More >>tav Carus, Medizinische Klinik, Dresden, Sachsen, 01307, Germany|Westdeutsches Tumorzentrum, Universitaetsklinikum Essen, Essen, 45112, Germany|Universitaetsklinik Mannheim GmbH, III. Medizinische Klinik, Mannheim, 68167, Germany Less <<
NCT00522886 Non-small Cell Lung Cancer PHASE1 COMPLETED - Maastricht Radiation Oncology,... More >> MAASTRO clinic, Maastricht, Limburg, Netherlands Less <<
NCT02994888 Metastatic Colorectal Cancer COMPLETED 2025-12-16 The Royal Marsden NHS Foundati... More >>on Trust, Surrey, Sutton, SM2 5PT, United Kingdom Less <<
NCT04853043 Colorectal Cancer PHASE2 TERMINATED 2024-05-03 Intermountain Medical Center, ... More >>Salt Lake City, Utah, 84107, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, 84112, United States Less <<
NCT06226857 Colorectal Neoplasms|Chemother... More >>apy Effect|Molecular Sequence Variation Less << PHASE3 RECRUITING 2027-12-31 Moscow Multidiciplinary Clinic... More >>al Center Kommunarka, Moscow, 108814, Russian Federation|N.N Blokhin Cancer Reserch Center, Moscow, 115478, Russian Federation|Reutov Clinical hospital, Reutov, 143964, Russian Federation Less <<
NCT04648189 Lung Cancer|Surgery|Circulatin... More >>g Tumor Cell Less << PHASE2 WITHDRAWN 2022-09-19 Amsterdam UMC - VUMC, Amsterda... More >>m, Netherlands|Leiden University Medical Center, Leiden, Netherlands Less <<
NCT01830556 Squamous Cell Carcinoma of the... More >> Head and Neck Less << PHASE2 UNKNOWN 2025-11-15 Lena Specht, Copenhagen, 2100,... More >> Denmark|Hedda Haugen, G?teborg, 413 45, Sweden|Karolinska Universityhospital, Stockholm, 17176, Sweden|Karin S?derstr?m, Ume?, 90189, Sweden|Akademiska Universityhospital, Uppsala, 751 85, Sweden Less <<
NCT01435252 Oropharyngeal Cancer|Hypophary... More >>ngeal Cancer|Laryngeal Cancer Less << PHASE2 COMPLETED 2017-10-25 University Hospital, Zurich, S... More >>witzerland Less <<
NCT01230476 Nasopharyngeal Carcinoma PHASE2 TERMINATED 2025-05-15 University Malaya Medical Cent... More >>re, Kuala Lumpur, Wilayah Persekutuan, 59100, Malaysia Less <<
NCT00251485 Colorectal Cancer PHASE2 COMPLETED 2025-06-05 Veeda Oncology, Houston, Texas... More >>, 77042, United States Less <<
NCT06440902 Colorectal Cancer Metastatic PHASE2 RECRUITING 2028-09-01 Fudan University Shanghai Canc... More >>er Center, Shanghai, Shanghai, 200032, China Less <<
NCT00130689 Esophageal Cancer|Gastric Canc... More >>er|Neoplasm Metastasis Less << PHASE2 COMPLETED 2025-09-10 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|North Shore Medical Center Cancer Center, Peabody, Massachusetts, United States Less <<
NCT00215722 Colorectal Carcinoma PHASE2 UNKNOWN 2025-07-08 Hospital Garcia de Orta, Almad... More >>a, 2800, Portugal|Hospital Distrital do Barreiro, Barreiro, 2830, Portugal|Hospital Distrital de Beja, Beja, 7800-309, Portugal|Hospital de S?o Marcos, Braga, 4700, Portugal|Hospitais da Universidade de Coimbra, Coimbra, 3000-075, Portugal|IPO - Coimbra, Coimbra, 3000, Portugal|Centro Hospitalar do Funchal, Funchal, 9000-514, Portugal|Hospital Pedro Hispano, Matosinhos, 4454-509, Portugal|Hospital do Divino Espírito Santo, Ponta Delgada, 9500-370, Portugal|IPO - Porto, Porto, 4200, Portugal Less <<
NCT00292955 Cancer of the Cervix PHASE2 UNKNOWN - Washinton University School of... More >> Medicine, St. Louis, Missouri, 63110, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States Less <<
 

Historical Records

Categories